X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.globenewswire.com/news-release/2024/03/19/2848411/33090/en/Axsome-Therapeutics-Initiates-PARADIGM-Phase-3-Trial-of-Solriamfetol-for-the-Treatment-of-Major-Depressive-Disorder.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-9-2023-9584.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-31-2023-56013.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-24-2023-89772.pdf
https://www.prnewswire.com/news-releases/long-grove-pharmaceuticals-secures-commercial-rights-to-an-essential-critical-care-medication-301816518.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-11-2022-1652250109.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-5-2022-1641361383.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf
https://www.prnewswire.com/news-releases/breckenridge-pharmaceutical-inc-announces-launch-of-norepinephrine-bitartrate-injection-usp-generic-for-levophed-301359736.html
https://www.lesechos.fr/pme-regions/centre-val-de-loire/chimie-fine-axyntis-relocalise-la-production-dactifs-pharmaceutiques-1312444
https://www.lesechos.fr/pme-regions/centre-val-de-loire/chimie-fine-axyntis-relocalise-la-production-dactifs-pharmaceutiques-1312444
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-May-1-2019-1556686753.pdf
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11192018103541
https://www.biospectrumasia.com/news/34/11904/axsome-receives-fda-orphan-drug-designation-for-narcolepsy-drug.html
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=8262018111931
https://www.prnewswire.com/news-releases/theravance-biopharma-reports-positive-top-line-four-week-data-from-phase-2-trial-of-td-9855-for-the-treatment-of-symptomatic-neurogenic-orthostatic-hypotension-300689891.html
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-July-25-2018-1532506531.pdf
https://www.fiercebiotech.com/shkreli-stocks-still-sharing-biotech-tips
https://endpts.com/fda-approves-first-non-opioid-to-treat-withdrawal-symptoms-in-adults/
https://www.forbes.com/sites/davidkroll/2018/02/28/antidepressant-migraine-drug-combination-found-less-risky-than-believed/#4b631c8e3496
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-2-2017-1501649040.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-21-2017-1498020666.pdf
http://www.drug-dev.com/Main/Current-News/Agilis-Biotherapeutics-Announces-First-Patient-Tre-1762.aspx
http://www.financialexpress.com/article/lifestyle/health/heres-how-trauma-sudden-sounds-form-lasting-memories-in-brain/125267/
http://www.prnewswire.com/news-releases/recent-cytosorb-case-reports-highlight-its-use-to-help-save-the-lives-of-critically-ill-patients-300007715.html
Market Place
Share 
